Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

1.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Steen DP, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061.

PMID:
25173516
[PubMed - in process]
2.

Darapladib for preventing ischemic events in stable coronary heart disease.

STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L.

N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.

PMID:
24678955
[PubMed - indexed for MEDLINE]
3.

Influence of epicardial stenosis severity and central venous pressure on the index of microcirculatory resistance in a follow-up study.

Pagonas N, Gross CM, Li M, Bondke A, Klauss V, Buschmann EE.

EuroIntervention. 2014 Jan 22;9(9):1063-8. doi: 10.4244/EIJV9I9A180.

PMID:
24457278
[PubMed - in process]
Free Article
4.

Reasons reported by African ophthalmologists for staying in Africa and for considering migrating.

Nentwich MM, Schaller UC, Klauss V.

Int Ophthalmol. 2014 Aug;34(4):887-92. doi: 10.1007/s10792-014-9896-x. Epub 2014 Jan 22.

PMID:
24448908
[PubMed - in process]
5.

Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.

Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S.

JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.

PMID:
23968698
[PubMed - indexed for MEDLINE]
Free Article
6.

Low-dose transscleral diode laser cyclophotocoagulation (TSCPC) as a potential single treatment for primary open-angle glaucoma (POAG) in Malawi?

Schulze Schwering M, Kayange P, Klauss V, Kalua K, Spitzer MS.

Graefes Arch Clin Exp Ophthalmol. 2013 Oct;251(10):2389-93. doi: 10.1007/s00417-013-2441-1. Epub 2013 Aug 21.

PMID:
23963489
[PubMed - indexed for MEDLINE]
7.

11 Years of experience in vitreoretinal surgery training in Nairobi, Kenya, from 2000 to 2010.

Schönfeld CL, Kollmann M, Nyaga P, Onyango O, Klauss V, Kampik A.

Can J Ophthalmol. 2013 Aug;48(4):324-30. doi: 10.1016/j.jcjo.2013.04.007.

PMID:
23931474
[PubMed - indexed for MEDLINE]
8.

Magnetic resonance perfusion of the myocardium: semiquantitative and quantitative evaluation in comparison with coronary angiography and fractional flow reserve.

Huber A, Sourbron S, Klauss V, Schaefer J, Bauner KU, Schweyer M, Reiser M, Rummeny E, Rieber J.

Invest Radiol. 2012 Jun;47(6):332-8. doi: 10.1097/RLI.0b013e31824f54cb.

PMID:
22543970
[PubMed - indexed for MEDLINE]
9.

Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.

Sinning JM, Baumgart D, Werner N, Klauss V, Baer FM, Hartmann F, Drexler H, Motz W, Klues H, Voelker W, Pfannebecker T, Stoll HP, Nickenig G; SCORPIUS Study.

Am Heart J. 2012 Mar;163(3):446-53, 453.e1. doi: 10.1016/j.ahj.2011.12.010.

PMID:
22424016
[PubMed - indexed for MEDLINE]
10.

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.

Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, van Es GA, Meier B, Windecker S, Jüni P.

Lancet. 2011 Dec 3;378(9807):1940-8. doi: 10.1016/S0140-6736(11)61672-3. Epub 2011 Nov 8.

PMID:
22075451
[PubMed - indexed for MEDLINE]
11.

The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).

Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, Di Mario C, Van Geuns RJ, Van Es GA, Juni P, Windecker S.

EuroIntervention. 2011 Nov;7(7):789-95. doi: 10.4244/EIJV7I7A125.

PMID:
22027687
[PubMed - indexed for MEDLINE]
Free Article
12.

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial.

Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, Di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW.

EuroIntervention. 2011 Sep;7(5):605-13. doi: 10.4244/EIJV7I5A97.

PMID:
21930465
[PubMed - indexed for MEDLINE]
Free Article
13.

2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.

Klauss V, Serruys PW, Pilgrim T, Buszman P, Linke A, Ischinger T, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, van Geuns RJ, van Es GA, Kalesan B, Wenaweser P, Jüni P, Windecker S.

JACC Cardiovasc Interv. 2011 Aug;4(8):887-95. doi: 10.1016/j.jcin.2011.03.017.

PMID:
21851904
[PubMed - indexed for MEDLINE]
Free Article
14.

[Intravascular ultrasound for recognition of atherosclerotic plaques and plaque composition. Current state of the diagnostic value].

König A, Klauss V.

Herz. 2011 Aug;36(5):402-9. doi: 10.1007/s00059-011-3485-9. Review. German.

PMID:
21732096
[PubMed - indexed for MEDLINE]
15.

Benefits, limitations and outcomes of vitreoretinal surgery, Nairobi, Kenya: 8-year experience.

Schönfeld CL, Nyaga P, Onyango OM, Klauss V, Kampik A, Kollmann M.

Acta Ophthalmol. 2012 May;90(3):e244-5. doi: 10.1111/j.1755-3768.2011.02153.x. Epub 2011 Jun 8. No abstract available.

PMID:
21649875
[PubMed - indexed for MEDLINE]
16.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention).

Stefanini GG, Serruys PW, Silber S, Khattab AA, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, Di Mario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli AL, Gobbens P, Windecker S.

J Am Coll Cardiol. 2011 May 31;57(22):2221-32. doi: 10.1016/j.jacc.2011.01.036.

PMID:
21616282
[PubMed - indexed for MEDLINE]
Free Article
17.

Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.

García-García HM, Klauss V, Gonzalo N, Garg S, Onuma Y, Hamm CW, Wijns W, Shannon J, Serruys PW.

Int J Cardiovasc Imaging. 2012 Apr;28(4):695-703. doi: 10.1007/s10554-011-9882-6. Epub 2011 May 19.

PMID:
21594650
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.

Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S.

JACC Cardiovasc Interv. 2011 Apr;4(4):432-41. doi: 10.1016/j.jcin.2011.01.008.

PMID:
21511223
[PubMed - indexed for MEDLINE]
Free Article
19.

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.

Silber S, Windecker S, Vranckx P, Serruys PW; RESOLUTE All Comers investigators.

Lancet. 2011 Apr 9;377(9773):1241-7. doi: 10.1016/S0140-6736(11)60395-4. Epub 2011 Apr 1.

PMID:
21459430
[PubMed - indexed for MEDLINE]
20.

Five-year clinical follow-up after sirolimus-eluting stent implantation for the treatment of coronary in-stent restenosis.

Schiele TM, Leibig M, Rieber J, König A, Krötz F, Sohn HY, Klauss V.

Coron Artery Dis. 2011 May;22(3):188-93. doi: 10.1097/MCA.0b013e3283423714.

PMID:
21394029
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk